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Although analytical precision in clinical chemistry has improved to generally acceptable levels, the problems of analytical bias and interlaboratory comparability of data have not yet been solved. Barriers that remain include nonspecific methods and matrix problems with calibration and control materials.
Quantification of total cholesterol in serum is one relatively exceptional case in which production of comparable and even accurate results has become possible by means of standardization efforts (1) (2) (3) (4) (5) (6) , whether through normalization of methods (2, 7) or the use of common materials and correction factors (8, whose methods show analytical bias have frequently improved the accuracy of their results by using a senun calibrator procedure.
Use of serum as a secondary standard instead of pure primary standard solutions is often unavoidable, particularly in continuous-flow systems, where use of calibration sera with assigned values is common-not only because of its convenience in multi-component analysis but also because of the matrix differences between serum and pure solutions.
For the KCA program we have developed three concentrations of serum calibrators, prepared from liquid human serum pools (2, 10). We have found that matrix differences between serum enriched with alcohol-precipitated lipids and serum enriched with heparin/Mn2-precipitated lipoproteins are more influential in Liebermann-Burchard procedures for cholesterol than in enzymatic methods. Having produced liquid sera with properties comparable with those of fresh serum from patients, we tested them in a pilot survey of 31 hospital laboratories in the Rotterdam area. The set of three serum calibrators and four specimens from pools of fresh sera were analyzed twice in each laboratory on two different days. We then extended the study throughout Holland, documenting the results with a thorough statistical analysis. In the broader study, liquid serum controls and two lyophilized control pools were distributed with the three calibrator pools. All sera were prepared and supplied from the National Institute of Public Health and Environmental Hygiene, Bilthoven, The Netherlands (10). The participants analyzed all materials on four different days. Results were compared with the target values, or reference method values, obtained by the manual Abell-Kendall Reference Method (CDC-modified) (11, 12) in the Reference Center in
Rotterdam.
Materials and Methods
In the pilot study, the results were based on "routine calibration" and corrected on the basis of a calibration line constructed manually with the results of the calibrators and the reference method values thereof. Among the participants, 24 used enzymatic methods, six the LiebermannBurchard procedure, and one a Pearson (iron-containing) reagent. In the broader study, eight sera produced by the National Institute of Public Health in Bilthoven were made available by the organizer of the standardization program (KCA) to 144 laboratories participating in the qualitycontrol scheme of the Netherlands Foundation for Q.C. in Hospital Laboratories (SKZL) (10). Six pools were liquid and kept frozen at -20 #{176}C, two were lyophilized. Three of the frozen pools were designated as calibrators and the other three as controls, the participants being ignorant of the differences. Each pool was supplied in four vials to be assayed on four days. Of the 138 laboratories that reported complete data, 115 used an enzymatic method, 23 a nonenzymatic one. The enzymatic kits used, and the number of participants using each, were: Boehringer CHOD-PAP 77, J. T. Baker 12, Technicon six, and SmithKline five. Eight more kits were used by only three or fewer laboratories in each case. The performance of the kits from many of the manufacturers was studied as well and has been published separately (13) . To test the effects of methodological differences, we classified the techniques used as manual, continuous-flow, centrifugal analyzer, reaction rate (kinetic), or discrete systems.
Whereas the statistical methods used in the pilot study were simple, we used more refined calculations in the largescale survey. After calculating the within-laboratory means from the four measurements for each pool, we computed the between-laboratory SD values and the overall means. We checked the homogeneity of within-group variances, which is assumed in unweighted analysis of variance, by comparing the within-lab.-within-serum variances against the average within-lab.-within-serum variance by using a chisquare test (14) . When a significantly deviating (p = 0.05) variance was flagged, the analytical results of that laboratory were inspected.
Invariably the outliers could be identified. If no more than one outlier was responsible for the excessive variance, we replaced that assay value with the mean of the other three values for that pool. This resulted in the replacement of 26 results (0.6% of all measurements). If there was more than one outlier, we removed the entire laboratory's results from the calculations. Results from six participants were thus deleted. To check the possible dependence of within-lab, variability on the cholesterol levels of the pools we tested the correlation between within-lab.-within-serum variance and assigned reference-method values, by applying a distribution-free trend test based on the Friedman test (15) to results from all eight pools. From these assessments we determined that a variance-weighted linear regression should be used for the calibration of results with the serum calibrators.
We have computed the average lab.
-mean values and average within-lab, variances per serum pool for the users of enzymatic and nonenzymatic procedures separately, according to analytical technique and overall. To detect possible between-method effects on slopes and intercepts of regression lines, we calculated variance-weighted linear regression coefficients from the results in each laboratory and averaged them for the various analytical methods. We then calculated the variance-weighted linear-regression lines for each laboratory from results for the three calibrator pools vs the target values. With these we corrected the results for the five other pools. We finally calculated the average values, average within-lab, variance and between-lab. variance components per serum pool, for participants with enzymatic and nonenzyrnatic methods, by analytical technique and overall, using the corrected results.
To test whether the correction with serum calibrators decreased the betweenlab. variance, we performed one-way analyses of variance for each control pool (numbers 4 through 8). To compare the mean squares between laboratories for results before and after correction, we used a test developed by Pitman (15) . (Because these mean squares are correlated, a simple F-test is not applicable.)
Results and Discussion
Results of the pilot study ( Table 2 summarizes the national survey data, listing the reference-method values and between-lab. SD for the enzymatic and nonenzyinatic methods used (listed in Materials and Methods). Most enzymatic products were used by too few of the participants to allow a thorough between-kit comparison. The mean values for the nonenzymatic methods reflect the well-known positive bias, which is caused mainly by the deletion of an extraction step in the routine procedure (17, 18). The overall mean results are close to the target values. The enzymatic methods, especially the manual ones, give low results, whereas the centrifugal and kinetic procedures give higher results, for reasons we can't explain. The between-lab, variation in the nonenzymatic group seems to be less than in the enzymatic assays. Table 3 . The total enzymatic-method group shows a small proportional error (slope = 0.973), whereas the group of non-enzymatic methods appears to have a constant error (0.280 mmol/L).
Although one might expect that the mean within-lab. precision might deteriorate slightly after a calibration procedure based on three serum samples-by including the imprecision of those analyses in the final values-we did not see this effect. If participants apply a single standard in their routine procedures, a systematic error is introduced throughout a run equal to the size of the random error in the determination of the standard. The use of three standards tends to average out this random error and to diminish the between-run variance. The use of the calibration line constructed to fit the measured points decreases the average within-lab. SDs, as shown in Table 4 for pools 4 through 8.
The overall effect on analytical bias and between-lab. variation compares well with our expectations (Table 5 ). The overall means are now closer to the reference-method values. The mean results of the various method groups are much closer to target than before (Table 2) , and the between-lab, SDs appear to have been much reduced! Of course, some enzymatic assays were accurate enough without recalibation.
According to the Pitman test the betweenlab, variance of the corrected results is in all cases signifi- The bias reduction resulting from our calibration procedure is swmnarized in Table 6 . The analytical bias, expressed as a percentage, is given for all pools and method groups.
Conclusions
Investigations on a small scale demonstrated that use of a serum calibration procedure could improve the results of routinely obtained cholesterol results. This was confirmed by a further investigation with data from 138 participants in an evaluation with 115 enzymatic and 24 non-enzymatic techniques. A Friedman test revealed a positive correlation between variance and cholesterol concentrations in the pools and linear-regression calculations were then performed, variance weighted.
A linear-regression line constructed with analytical results from three serum calibrators was used to correct the values of the five other pools. Analysis of variance applied to the original results yielded highly significant between-lab. variance components for all sera. Testing the between-lab. variances of the corrected results against those of the noncorrected ones by means of the Pitman test demonstrated a highly significant improvement of interlaboratory comparability. Mean results for participants in subgroups by various methods did not differ more than ± 3.5% from the referencemethod values (manual Abell-Kendall; CDC modification). Within-lab, precision was improved in the non-enzymatic group. Between-lab.
variance components were significant, even in the subgroup that used the same enzymatic kit. These were also significantly improved after recalibration.
The three serum calibrators of the KCA as produced by the National Institute of Public Health had a comparable effect on liquid serum pools (nos. 4, 5 and 6) and on lyophilized pools (nos. 7 and 8) , suggesting that use of lyophilized calibration sera might be appropriate. These two cholesterol calibrators (7 and 8) ' Calibratorsand serum pools numbered as in Table 4 ; n foreach comparison as in Table 4 .
effects of such materials should, however, always be studied dures in clinical chemistry laboratories can benefit from the in the analytical techniques to be calibrated. An additional use of accepted reference methodology in cases where its interesting result of the study is the discussion it has application is feasible. Table 3 . It remains to be established whether our serum calibration procedure nevertheless would set a better standard.
